Septal perforation repair techniques
Advancement flaps, bridge flap, pedicled flaps, fascia lata, TPF-PDS, perfoplasty: ten techniques, seven of which actually close the hole. Every closure rebuilds the three layers of the septum; they differ in how they bring in the supporting tissue and the mucosa that covers it. Two words to know: a graft is tissue cut from its blood supply and transplanted; a flap is tissue moved while staying connected.
Written by the Septal Perforation team, patients, from the sources cited · Reviewed by doctors · Updated 2 November 2026 · Method and sources
The three principles
Plug it
A septal button places a silicone disc on each side of the hole and passes through it. Nothing is repaired: it is a prosthesis, and a foreign body that can enlarge the perforation.
Advance the mucosa
Neighbouring mucosa is lifted and slid across to cover the hole on both faces. This is the commonest approach; it spends mucosa from inside the nose.
Interpose a support
A support tissue (fascia, cartilage, resorbable plate) is slid between the two mucosal layers, which heal over it. This approach takes almost nothing from inside the nose.
Seven techniques that close the hole
Each technique has its own detailed page: the operation, the sizes it targets, the published series with their follow-up, the risks and the questions to ask.
Two options that do not close the hole
The septal button plugs the hole with a prosthesis; perfoplasty smooths its edges to remove crusting and turbulence. Neither repairs the septum: the 2026 consensus reserves the button for patients who cannot or do not want surgery, and perfoplasty is discussed for posterior perforations or those judged unclosable.
Still experimental
Cartilage grown from your own cells, PRP, 3D printing: avenues in clinical trials, not yet treatments.
Everything side by side
| Technique | Harvest | Sizes targeted | Best published rate | Reversible |
|---|---|---|---|---|
| Close the hole | ||||
| Bilateral advancement flaps with interposition graft | Septal and nasal floor mucosa | Up to 2 cm, and beyond in expert centres | 94.8% in 392 patients (Mayo Clinic); 95% in 154 patients in the UK; 86% in 81 endonasal repairs | No |
| Bipedicled bridge flap | Mobilises all the septal mucosa, from roof to inferior meatus | Large and subtotal, beyond 2 × 3 cm | 72% durable closure at 67 months (Ulm series, the only long follow-up published); 93.8% short-term in 92 patients | No |
| Anterior ethmoidal artery flap | Mucosa from the upper septum | Anterior perforations, small to large (bilateral beyond 2 cm) | 11 of 11 closed at 51 months in the original series; 83% unilateral versus 92.3% bilateral | No |
| Floor, turbinate and lateral wall flaps | The floor, the inferior meatus, sometimes a turbinate | Small and medium, lower third or lower three quarters of the septum | Complete closure in all 5 patients and 10 cadaver specimens of the reference series; clinical series are still short | No |
| Temporoparietal fascia and PDS plate | Nothing from inside the nose (temple harvest) | Medium; up to 4.5 cm in a recent series | 90% in two independent series; 62 patients across 7 institutions with improved NOSE scores | No |
| Fascia lata and costal cartilage | Nothing from inside the nose (thigh, sometimes rib) | Large, beyond 2 cm | 92% in 25 patients all above 2 cm at 12 months; 86.3% at 12 months with Tricellufuse; 30/30 closed at 6 months in 2026 | No |
| Pericranial flap and salvage options | Nothing from inside the nose (skull harvest) | Total and subtotal, repeated failures | 91.2% closure in total perforations | No |
| Without closing the hole | ||||
| Septal button | Nothing from inside the nose | Any size, if a complete rim of tissue surrounds the hole | 50.6% of wearers needed no further procedure at 5 years; 14 of 41 still wore their button after 1 to 9 years | Yes, completely |
| Perfoplasty and posterior enlargement | Almost nothing | Any, especially posterior or judged unclosable | Acceptable symptom control in 18 of 20 patients (90%), improvement in a median of 66 days | Partly |
| Experimental | ||||
| Regenerative techniques | A few septal cartilage cells | 0.5 to 2 cm in the phase I trial | Feasibility shown in 5 patients (phase I trial); no comparative efficacy established | No |
These rates come from different series, with different definitions of success and different follow-up: read them as orders of magnitude, not as a ranking.
From the 2026 Springer textbook
Seven more techniques
Not sure which one applies to you? The 4-question guide points you in the right direction.
Keep reading